Innocare

    OverviewSuggest Edit

    InnoCare is a technology company offering clinic management software and services for healthcare, rehabilitation, and wellness professionals. It provides a platform that connects clinics and patients in their area.

    TypePrivate
    Founded2016
    HQBurlington, CAMap
    Websiteinnocare.ca

    Recent NewsAll News

    Latest Updates

    Employees (est.) (Jul 2021)25(-7%)
    Cybersecurity ratingBMore

    Innocare Office Locations

    Innocare has an office in Burlington
    Burlington, CA (HQ)
    3215 N Service Rd
    Show all (1)

    Innocare Financials and Metrics

    Summary Metrics

    Founding Date

    		2016

    Innocare Cybersecurity Score

    Cybersecurity ratingPremium dataset

    B

    85/100

    Learn more about our premium products
    SecurityScorecard logo

    Innocare Online and Social Media Presence

    Innocare's Trends

    Embed Graph

    Innocare News and Updates

    June 28, 2021

    InnoCare Announces Breakthrough Therapy Designation of Orelabrutinib by US FDA for Treatment of R/R MCL

    BEIJING, June 28, 2021 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to its Bruton's tyrosine kinase (BTK) inhibitor orelabrutinib for...
    June 18, 2021

    InnoCare Presents Latest Clinical Data of Orelabrutinib at the16th International Conference on Malignant Lymphoma

    BEIJING, June 18, 2021 /PRNewswire/ -- InnoCare (HKEX: 09969), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced today the company presented the latest clinical data of the Bruton's tyrosine kinase (BTK) inhibitor orelabrutinib at the 16th...
    June 17, 2021

    InnoCare Announces Orphan Drug Designation of Gunagrabtinib by US FDA for Treatment of Cholangiocarcinoma

    BEIJING, June 16, 2021 /PRNewswire/ -- InnoCare (HKEX: 09969), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced today that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its pan-FGFR inhibitor gunagratinib...
    March 26, 2021

    InnoCare Releases 2020 Annual Results and Business Highlights

    BEIJING, March 26, 2021 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced 2020 annual results which ended on Dec. 31, 2020. Dr. Jasmine Cui, Co-founder, Chairwoman and CEO of InnoCare, said,...
    January 31, 2020

    Biotech Firm InnoCare Delays Hong Kong IPO Step on Virus Fears

    Biotech Firm InnoCare Delays Hong Kong IPO Step on Virus Fears
    May 08, 2019

    Chinese Biotech Firm InnoCare Plans Hong Kong IPO

    Chinese Biotech Firm InnoCare Plans Hong Kong IPO

     Innocare Frequently Asked Questions

    • When was Innocare founded?

      Innocare was founded in 2016.

    • How many employees does Innocare have?

      Innocare has 25 employees.

    • Who are Innocare competitors?

      Competitors of Innocare include Veta Health, Tencent Trusted Doctors and VIS.

    • Where is Innocare headquarters?

      Innocare headquarters is located at 3215 N Service Rd, Burlington.

    • Where are Innocare offices?

      Innocare has an office in Burlington.

    • How many offices does Innocare have?

      Innocare has 1 office.